Understanding the Recent Fluctuations of Sabra Healthcare REIT Inc’s (SBRA) Stock

The stock of Sabra Healthcare REIT Inc (SBRA) has gone up by 1.04% for the week, with a 4.36% rise in the past month and a 2.31% rise in the past quarter. The volatility ratio for the week is 1.71%, and the volatility levels for the past 30 days are 1.84% for SBRA. The simple moving average for the last 20 days is 2.50% for SBRA’s stock, with a simple moving average of 8.83% for the last 200 days.

Is It Worth Investing in Sabra Healthcare REIT Inc (NASDAQ: SBRA) Right Now?

Sabra Healthcare REIT Inc (NASDAQ: SBRA) has a higher price-to-earnings ratio of 250.00x compared to its average ratio, The 36-month beta value for SBRA is at 1.17. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 as “hold,” and 1 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The public float for SBRA is 227.78M, and currently, shorts hold a 5.44% of that float. The average trading volume for SBRA on April 03, 2024 was 2.06M shares.

SBRA) stock’s latest price update

Sabra Healthcare REIT Inc (NASDAQ: SBRA) has experienced a decline in its stock price by -0.75 compared to its previous closing price of 14.71. However, the company has seen a gain of 1.04% in its stock price over the last five trading days. CNBC Television reported 2024-03-25 that The Investment Committee give you their top stocks to watch for the second half.

Analysts’ Opinion of SBRA

Many brokerage firms have already submitted their reports for SBRA stocks, with Deutsche Bank repeating the rating for SBRA by listing it as a “Buy.” The predicted price for SBRA in the upcoming period, according to Deutsche Bank is $21 based on the research report published on January 30, 2024 of the current year 2024.

BMO Capital Markets, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $16. The rating they have provided for SBRA stocks is “Market Perform” according to the report published on October 17th, 2023.

Wells Fargo gave a rating of “Equal Weight” to SBRA, setting the target price at $15 in the report published on October 16th of the previous year.

SBRA Trading at 5.41% from the 50-Day Moving Average

After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.08% of loss for the given period.

Volatility was left at 1.84%, however, over the last 30 days, the volatility rate increased by 1.71%, as shares surge +3.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.91% upper at present.

During the last 5 trading sessions, SBRA rose by +1.04%, which changed the moving average for the period of 200-days by +23.10% in comparison to the 20-day moving average, which settled at $14.27. In addition, Sabra Healthcare REIT Inc saw 2.31% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at SBRA starting from Costa Michael Lourenco, who purchase 1,947 shares at the price of $12.63 back on Sep 01 ’23. After this action, Costa Michael Lourenco now owns 183,218 shares of Sabra Healthcare REIT Inc, valued at $24,591 using the latest closing price.

Stock Fundamentals for SBRA

Current profitability levels for the company are sitting at:

  • 0.5 for the present operating margin
  • 0.63 for the gross margin

The net margin for Sabra Healthcare REIT Inc stands at 0.02. The total capital return value is set at 0.06. Equity return is now at value 0.47, with 0.25 for asset returns.

Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.46 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.86. The interest coverage ratio of the stock is 2.54.

Currently, EBITDA for the company is 418.15 million with net debt to EBITDA at 5.71. When we switch over and look at the enterprise to sales, we see a ratio of 8.91. The receivables turnover for the company is 1.31for trailing twelve months and the total asset turnover is 0.12.


In conclusion, Sabra Healthcare REIT Inc (SBRA) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts